The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, neuromodulation systems, and diagnostic solutions industry.

The issue features advanced medical devices such as intelligent drug delivery system, immersive therapeutics for treating vision impairment, active cerebrospinal fluid (CSF) filtration, autonomous robotic blood collection system, smart orthopedic implant, semi-automated urine chemistry analyzer, laparoscopic renal denervation, and surgical robotic system for high precision subretinal procedures.

It also highlights wearable technologies, including wearable neurotherapeutic systems, chip-less wearable neuromorphic systems, and wireless wearable bioimpedance sensors. The issue explores neuromodulation innovations such as non-invasive ultrasound neuromodulation and auricular vagus nerve stimulators. In addition, it covers artificial intelligence (AI)-powered solutions, including AI-integrated health monitoring systems and AI-driven fetal ultrasound diagnostics. Diagnostic innovations featured in the issue include mechanobiology-based in vitro cancer diagnostics, point-of-care devices for diagnosing antimicrobial resistance, and epigenomic cancer detection diagnostics.

• What are the new technologies, advances in R&D, product development and regulatory matters influencing future growth potential?
• Which growth drivers are transforming wearables, implantable, diagnostics, surgical tools and instrumentation, image guided surgery, drug delivery, patient monitoring, digital health, and medical imaging?
• How can you grow by leveraging cutting-edge global developments in biosensors, biomaterials, biomechanics, nanotechnologies, assistive technologies, and imaging platforms?